 BOULDER, Colo., March 08, 2022 GLOBE NEWSWIRE -- Brickell Biotech, Inc. Brickell or the Company Nasdaq: BBI, a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoimmune, inflammatory and other debilitating diseases, announced today that it will report its fourth quarter and full year 2021 financial results on Tuesday, March 15th. Brickells management will host a conference call and webcast at 8:30 a.m. EDT that same day to discuss the financial results and recent corporate highlights. 